Published in Virus Weekly, September 12th, 2006
"Dr. Coussens' in-depth knowledge of molecular virology will be a great asset to us in the development of our new cell-culture based vaccine to protect against the spread of influenza viruses, including the highly lethal H5N1 avian flu virus," stated Harmel S. Rayat, president and CEO of HepaLife Technologies.
"Due to the threat of the deadly H5N1 virus being spread by migratory birds, which are now nesting in Alaska and Canada and will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly